Sai Life Sciences Limited (NSE:SAILIFE)

Sai Life Sciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	192,412	158,581	-	-	-	-
Enterprise Value	191,297	166,413	-	-	-	-
Last Close Price	918.20	760.85	-	-	-	-
PE Ratio	77.27	93.21	-	-	-	-
Forward PE	67.32	72.51	-	-	-	-
PS Ratio	10.07	9.36	-	-	-	-
PB Ratio	9.04	7.45	-	-	-	-
P/TBV Ratio	9.09	7.49	-	-	-	-
P/OCF Ratio	-	50.50	-	-	-	-
EV/Sales Ratio	10.01	9.82	-	-	-	-
EV/EBITDA Ratio	37.50	46.28	-	-	-	-
EV/EBIT Ratio	53.85	61.49	-	-	-	-
Debt / Equity Ratio	0.17	0.17	0.95	1.05	1.10	0.78
Debt / EBITDA Ratio	0.69	0.88	3.28	5.80	8.18	4.12
Debt / FCF Ratio	-	-	11.40	8.77	-	-
Asset Turnover	-	0.62	0.66	0.56	0.44	-
Inventory Turnover	-	4.97	4.27	3.50	3.04	-
Quick Ratio	-	1.58	1.05	0.93	0.99	1.05
Current Ratio	-	2.05	1.28	1.27	1.32	1.34
Return on Equity (ROE)	-	10.96%	8.89%	1.13%	0.71%	-
Return on Assets (ROA)	-	6.22%	4.83%	1.90%	0.98%	-
Return on Capital (ROIC)	-	7.72%	5.78%	2.25%	1.15%	-
Return on Capital Employed (ROCE)	-	11.10%	11.20%	4.60%	2.10%	7.10%
Earnings Yield	1.27%	1.07%	-	-	-	-
FCF Yield	-	-0.35%	-	-	-	-
Buyback Yield / Dilution	-12.26%	-8.04%	-0.27%	-0.46%	-5.32%	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.